Analyst Ratings for Mirati Therapeutics (MRTX)

MRTX Rating Summary

  |   Expand Research on MRTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.1 / 10   Percentile Rank: 27%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/20/2023 Citi Yigal Nochomovitz Downgrade Neutral
(Buy)		 59.00
(48.00)		 57.80
(58.70)		 1.56% Details
11/7/2023 Leerink Partners Andrew Berens Downgrade Market Perform
(Outperform)		 58.00
(78.00)		 56.27
(58.70)		 4.32% Details